These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 415919)

  • 21. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages.
    Neumann C; Macher E; Sorg C
    Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
    Wolmark N; Levine M; Fisher B
    J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved survival mediated by Corynebacterium parvum following allogeneic bone marrow transplantation in rabbits.
    Parker JR; Manuel G; Jacobs P
    Exp Hematol; 1982 Jan; 10(1):56-63. PubMed ID: 7037435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
    Castro JE; Sadler TE; Jones PD
    Dev Biol Stand; 1977 Apr 13-15; 38():277-81. PubMed ID: 608510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL; Lambert LH; Remington JS
    Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of 3H-thymidine-labelled C. parvum in mice.
    Sadler TE; Cramp WA; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():137-43. PubMed ID: 608501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of spleen cell growth and DNA polymerase activity by Corynebacterium parvum.
    Maruyama Y; Coleman MS
    Cancer Res; 1978 Jun; 38(6):1617-20. PubMed ID: 647675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
    Miyata H; Himeno K; Miake S; Nomoto K
    Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
    Urano M; Yamashita T; Suit HD; Gerweck LE
    Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.
    Minton JP; Rossio JL; Dixon B; Dodd MC
    Clin Exp Immunol; 1976 Jun; 24(3):441-7. PubMed ID: 1084821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple estimation of macrophage activity in tumour-bearing animals treated with Corynebacterium parvum.
    Wilson RG
    Br J Exp Pathol; 1981 Aug; 62(4):347-9. PubMed ID: 7295527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
    Chen MF; Suzuki H; Yano S
    Anticancer Res; 1992; 12(2):451-6. PubMed ID: 1580562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
    Webster DJ; Chare MJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies using labelled C. parvum preparations in mice.
    Scott MT
    Dev Biol Stand; 1977 Apr 13-15; 38():123-7. PubMed ID: 608498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical properties of the principle in C. parvum that produces splenomegaly in mice.
    Riveros-Moreno V; Niblock A
    Immunology; 1979 Mar; 36(3):495-9. PubMed ID: 220183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
    Miyata H; Nomoto K; Takeya K
    Immunology; 1980 May; 40(1):33-9. PubMed ID: 6968291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of C. parvum on a solid, subcutaneous mouse tumour.
    Jones PD; Sadler TE; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():259-64. PubMed ID: 204533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.